期刊文献+

123例老年肺癌临床特征分析 被引量:8

下载PDF
导出
出处 《中国老年学杂志》 CAS CSCD 北大核心 2008年第6期598-600,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献9

  • 1Yancik R.Cancer burden in the aged[J].Cancer,1997;80:1273-83.
  • 2杨玲,李连弟,陈育德,Donald Maxwell Parkin.中国肺癌死亡趋势分析及发病、死亡的估计与预测[J].中国肺癌杂志,2005,8(4):274-278. 被引量:168
  • 3Hurria A,Kris MG.Management of lung cancer in older adults[J].CA Cancer J Clin,2003;53(6)∶325-41.
  • 4Penson RT,Daniels KJ,Lynch TJ.Too old to care[J]? Oncologist,2004;9:343-52.
  • 5Langer CJ,Leighion JC,Comis RL,et al.Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity,response,and survival analysis[J].J Clin Oncol,1995;13:1860-70.
  • 6Shepherd FA,Abratt RP,Anderson H,et al.Gemcitabine in the treatment of elderly patients with advanced non-small cell lung cancer[J].Semin oncol,1997;24(Suppl 7): S50-5.
  • 7Cveronesi A,Crivellari A,Magri MD,et al.Vinorelbine treatment of advanced non-small cell lung cancer with special emphasis on elderly patients[J].Eur J Cancer,1996;32A:1809-911.
  • 8Feliu J,Gomez LL,Madronal C,et al.Gemcitabine plus vinorelbine in non-small cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin[J].Cancer,1999;86:1463-9.
  • 9Wasil T,Lichtman SM.Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly[J].Oncologist,2005;10(8):602-2.

二级参考文献23

  • 1李连弟,鲁凤珠.1990—1992年中国恶性肿瘤死亡流行分布情况分析[J].中华肿瘤杂志,1996,18(6):403-407. 被引量:227
  • 2李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 3Jensen OM, Esteve J, Moller H, et al. Cancer in the European Community and its member states. Eur J Cancer, 1990, 26(11-12): 1167-1256. Erratum in: Eur J Cancer, 1991,27 (12):1717.
  • 4European Network of Cancer Registries (ENCR). (2001) EURO CIM version 4. 0. European Incidence Database V2. 3. Lyon:IARC Press,2001.
  • 5Bray F, Sankila R, Ferlay J, et al. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer,2002,38(1): 99-166.
  • 6Yang L, Parkin DM, Ferlay J, et al. Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev, 2005,14(1): 243-250.
  • 7International Agency for Research on Cancer. IARC monographs on the Tobacco Smoke and Involuntary Smoking (Vol. 83). Lyon:IARC Press,2004.
  • 8Liu BQ, Peto R, Chen ZM, et al. Emerging tobacco hazards in China: 1. Retrospective proportional mortality study of one million deaths. BMJ,1998,317(7170) : 1411-1422.
  • 9Clinical Trial Service Unit, Oxford University. Emerging Tobacco Hazards in China. http:∥rum. ctsu. ox. ac. uk/tobacco.
  • 10Ferlay J, Bray F, Pisani P, et al. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide, Version 2. 0. IARC CancerBase No. 5. Lyon: IARC Press,2004.

共引文献167

同被引文献53

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部